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ABSTRACT 
 
Effectiveness of Pharmacist Delivered Medication Reconciliation Interventions 
on Hospital Readmission Rates: A Literature Review  
 
By 
 
Charles S. Lee 
 
July 27, 2017 
 
 
Introduction: Unnecessary hospital admissions and readmissions can expose 
individuals to potential risks such as unnecessary treatment and can be costly to 
both hospitals and to patients. Approximately one in every five hospital 
discharges of Medicare patients is readmitted to the hospital within 30 days of 
discharge and the annual cost of unplanned hospital readmissions is about $17.4 
billion. Under the ACA provision, the Centers for Medicare & Medicaid Services 
(CMS) reduces payments to hospitals that have excess 30-day readmission rates. 
Therefore, hospitals are particularly focused on reducing hospital readmission 
rates. Pharmacist-delivered interventions may be one strategy that hospitals can 
implement which may reduce readmission rates. 
  
Purpose: Although medication reconciliation is recognized as one of the most 
effective strategies for reducing hospital readmission, the evidence regarding the 
effectiveness of pharmacist-delivered medication reconciliation interventions, 
specifically, on hospital readmission rates is mixed. The aim of this literature 
review is to investigate available evidence regarding the clinical and financial 
impact of pharmacist-delivered medication reconciliation interventions across a 
variety of interventions and to suggest next steps for future research, practice and 
policies based on this evidence. 
 
Methods: To find available data for pharmacist-delivered medication reconciliation 
on hospital readmission, four electronic databases were used for selecting articles: 
ProQuest Central, Pubmed, Medline, CINAHL, Wiley Online library were used. 
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During the database search, the following main keywords used were ‘medication 
reconciliation,' ‘transition of care,’ ‘pharmacy,' ‘adverse drug event,’ and ‘patient 
readmission.' Searches were limited to articles published in English. 
 
Results: Several studies suggest that the impact of pharmacist-led medication 
reviews on hospital readmission rates is not clear. Some evidence does suggest, 
however, that pharmacist-led medication reconciliation programs does have a 
significant impact on improving drug-related readmissions, particularly among 
low health literacy patients, and may facilitate cost containment. More research is 
needed to address confounding factors and the role of pharmacy teams such as 
pharmacy interns or pharmacy technicians. 
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Chapter 1Introduction 
 
1.1 Background 
 
Reducing avoidable hospital admissions and readmissions are important quality 
metrics of the healthcare system. Unnecessary hospital admissions and readmissions can 
expose individuals to potential risks such as unnecessary treatment and can add costs to both 
hospital and to patients. Avoidable hospital admissions and readmissions also significantly 
contribute to rising cost of the healthcare system in the United States. Approximately one in 
every five hospital discharges of Medicare patients is readmitted to the hospital within 30 
days of discharge and the annual cost of unplanned hospital readmissions is about $17.4 
billion (Jencks, Williams & Coleman, 2009). Some readmissions are unavoidable, but some 
are the result of poor quality of care, lack of discharge planning and adequate transition of 
care, inadequate coordination of care, or lack or limited patient access to post-hospital care 
(such as rehabilitation facilities). Goldfield, McCullough & Hughes (2008) state that across 
all insured patients, around 11 percent of hospital readmissions are preventable.  
 
According to executive review by Jweinat, (2010) sociodemographic factors such as 
age, race, and type of insurance and severity of illness pose a high risk of hospital 
readmission. Increasing age has been showing consistent increase of patients’ hospital 
readmission and likelihood of readmission for African American and Hispanic patients is 
higher than that for Caucasians and other racial groups. Also, Medicaid-insured patients were 
more likely to be readmitted than patients with commercial insurance. Another study 
conducted by Silverstein et al. (2008) demonstrated that the following factors increased 
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relative risk of 30-day readmission: African American, male, and increasing of age older than 
or equal to 70. Lavernia, Villa & Jacobelli, (2013) suggests that these factors are possibly 
related to readmissions due to racial discrepancy and socioeconomic status of patients. Racial 
discrepancy is the difference between racial groups. Being African American and Hispanic 
race increase risk of having low health literacy and lower socioeconomic status also increase 
risk of having low health literacy (Vernon et al. 2007) Then, Bailey et al. (2015) found people 
with lower health literacy has 23% increased risk of 30-day hospital readmission rate. . 
 
Jweinat (2010) states the presence of comorbidity increases the risk for readmission 
by 1.3 to 6.9 percent, compared with having no comorbidities. The comorbidities were 
conditions affecting major organs and systemic conditions. Research by Graham et al.  
(2015) found interesting trends of timing in readmission. Patients discharged between 8 a.m. 
and 1 p.m. were less likely to be readmitted to hospital possibly due to presence of family 
caregivers helping them to receive information and arranging any necessary scheduling.  
 
In order to minimize unnecessary spending of hospital and open opportunities for 
billions of dollars of saving within a hospital, the Affordable Care Act (ACA) was created to 
decrease cost, increase access to health care, and improve the quality of health care. Under 
the ACA provision, the Centers for Medicare & Medicaid Services (CMS) reduces payments 
to hospitals that have excess 30-day readmission rates written in Section 3025 (U.S. Congress 
2010). The ultimate goal of Section 3025 is to reduce preventable hospital readmissions, 
prevent hospitalizations, and improve health outcomes. CMS mainly targets health conditions 
using hospital readmission rate as key measurement. As of 2016, CMS provided a list of 
covered conditions to include 30-day readmissions for Heart attack, Heart failure (HF), 
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Pneumonia, Chronic obstructive pulmonary disease (COPD) and Elective total hip and total 
knee replacements. CMS are including new conditions as needed and in order to avoid 
penalties, hospitals must find a way for better transition of care, coordination of care, and on 
the care upon patient discharge among these conditions. 
 
Focusing on reducing hospital readmission rates provides both opportunities and 
expectations for pharmacists. Clinical pharmacists are expected to use their expertise of 
medication knowledge in several ways to deal with readmission problems. One of the main 
roles of pharmacists is conducting medication reconciliation, although such procedure is not 
always available for everyone, depending on the hospitals. Medication reconciliation is 
defined as “a process of identifying the most accurate list of all medications a patient is 
taking — including name, dosage, frequency, and route — and comparing the patient’s 
current list of medications against the physician’s admission, transfer, and/or discharge orders” 
(Institute for Healthcare Improvement, [IHI], n.d.). Medication reconciliation interventions 
by pharmacists are showing valuable impact on hospital readmission rate. Polinski et al. 
(2016) conducted a study that used hospital-based medication reconciliation program which 
cut readmission rates by 50%, lowering overall risk of hospital readmission from 22% to 11%.  
 
In addition to the risk factors that have been discussed before, there is one other 
important factor that has been showing impact on hospital readmission rate, which is Adverse 
Drug Event (ADE). As soon as patients are admitted to a hospital, unintended therapeutic 
changes are common, and suboptimal communication during the transition may result in 
medication errors, which could lead to potential harm (Mekonnen, McLachlan & Brien, 
2016). According to the Brown (2013), 23.4 percent of readmission in elderly patients and 4.5 
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percent of all-cause readmissions are associated with ADEs. Poor communication of medical 
information at transitional times in care is responsible for as many as 50% of all medication 
errors in the hospital and up to 20% of ADEs (Poole, Chainakul, Pearson & Graham 2006). 
  
Considering the distinct knowledge and skills that pharmacists possess relating to 
medication therapy, they should be directly involved in the medication reconciliation process 
and their involvement may reduce adverse outcomes (Super, Phillips, Coffey & Patterson, 
2014). Preventable ADEs occur frequently at transitions in care. According to McLachlan, Yi, 
Ling & Jardine, (2014) and Dalleur, Beeler, Schnipper, & Donze, (2017), the ADEs related 
hospital readmissions were 13.1% and 19.3%, respectively.   
 
At discharge, pharmacists can conduct patient-centered medication reconciliation, in 
order to confirm that there is no complication between previous medications and medications 
that patients will take upon discharge. Pharmacists also educate patients to let them know 
what and how they should take the medications, provide adherence counseling, communicate 
with patients’ primary care provider (PCP) to minimize medication errors, and contact 
patients to listen to any problems such as side effects and any other concerns that affect 
adherence (Brown, 2013). Pharmacists are uniquely positioned to prevent ADEs, and 
involving pharmacists on patient education upon discharge or at admission can influence 
outcomes and reduce readmissions (Anderegg et al., 2014). 
 
1.2 Purpose of capstone 
  
Although medication reconciliation is recognized as one of the most effective 
strategies for reducing hospital readmission, the effectiveness of pharmacist-delivered 
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medication reconciliation on hospital readmission rates is not yet concrete. A recent study by 
Mueller et al. (2012) supports that pharmacist-led medication has better outcomes than other 
medication reconciliation interventions led by a nurse or physician. However, it is difficult to 
assess what types of interventions actually reduce readmissions as pharmacists are involved 
in a variety of settings, and there are mixed results in regards to pharmacist-involved 
medication reconciliation. The aim of this literature review is to investigate available 
evidence regarding pharmacist-delivered medication reconciliation interventions on hospital 
readmission rates across a variety of interventions to evaluate clinical and financial impact of 
pharmacist effectiveness.   
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Chapter 2 Method 
 
To find available data for pharmacist-delivered medication reconciliation on hospital 
readmission, four electronic databases were used for selecting articles: ProQuest Central, 
Pubmed, Medline, CINAHL, Wiley Online library were used. During the database search, the 
following main keywords used were ‘medication reconciliation,' ‘transition of care,’ 
‘pharmacy,' ‘adverse drug event,’ and ‘patient readmission.' Searches were limited to articles 
published in English 
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Chapter 3 Review of Literature 
 
3.1. Study characteristics 
 
 
Of the 15 identified studies, there were 8 studies which reported a positive impact of 
pharmacist-administered medication reconciliation interventions on readmission rates, 1 
study which reported mixed results and 5 studies which reported null results. Table 1 shows 
overview of identified studies.  
 
3.2 Literature Review 
 
A study conducted by Sebaaly et al. (2015) focused on investigating patient safety 
and cost associated with medication errors by delivering pharmacist-led medication 
reconciliation upon patients discharge. The prospective, cross sectional pilot study was 
conducted. Patients who were 18 years of age or older who were discharged from Monday 
through Friday for a 7-week period from September to October 2013 were included. A total 
of 77 patients were contacted, and ten patients were not able to have discharge verification, 
thus the remaining 67 patients were assessed. The workflow of the medication review process 
for this study started with discharge orders. As soon as discharge orders were written, nurses 
paged pharmacists, then pharmacists reviewed medication and contacted physicians with any 
medication errors. The time to complete the entire review by the pharmacist was recorded. 
Each condition was recorded in a severity scale, which was Lethal ($3000/error), Serious 
($2000/error), Significant ($500/error), Minor ($50/error), and No Harm to Patient.  The cost 
avoidance associated with each error was determined using methods described by Nesbit et al 
(2000). Then the 30-day readmission rate was also evaluated to compare these outcomes with 
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a control group which was from a historical cohort of patients admitted and discharged from 
the same units from July and August 2013. During the 7-week study period, pharmacists 
performed 67 discharge medication reviews and identified 84 errors. The price of cost saving 
varied according to the severity of ADE identified. In the end, the 30- day readmission rate in 
the study cohort was 18%, compared with 20% in the control group. The result number was 
numerically low, but it was not statistically significant. Based on the severity scale and 
pharmacist salaries, the intervention resulted in $42,300 in cost avoidance (Sebaaly et al., 
2015). 
 
Anderegg et al. (2014) conducted an observational pre-post analysis study at an 
academic medical center. The 30-day readmission rate was compared during three month 
periods before and after implementation of a restructured pharmacy practice model. The 
model includes medication reconciliation at transitions of care for every patient and discharge 
education for a high risk subgroup. There was a pharmacist to patient ratio of 1:30 on acute 
care floors and 1:18 on critical care units. The high risk subgroup was classified as those 
patients using any of Anticoagulation congestive heart failure, COPD, and Pneumonia 
medication. A total of 3,316 patients were included in the study. Of those participants, 
pharmacy teams completed medication reconciliation on 95.8 percent of cases at admission 
and 69.7 percent of cases at discharge. Contacting all patients was not possible due to the 
pharmacy team schedule and early discharges of patients. Discharge education was provided 
to 73.5 percent of high risk patients. There were 325 high risk patients in pre-implementation 
and 358 at post-implementation. No significant difference was present among the non- high 
risk subgroup, but there was a significant reduction in the high-risk subgroup. In the high-risk 
subgroup, (p= 0.042); cost projection indicated that this reduction could yield annual district 
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cost savings of more than $780,000 (Anderegget al., 2014). 
 
A pilot study conducted by Guandi et al. (2015) showed benefits of developing and 
implementing a pharmacy-led transitions of-care program to reduce the risk of readmission 
and increase satisfaction for HF patients. A medication discrepancy, the difference of 
medication that a patient was taking before admission and taking as ordered medication, was 
common at St.Peter Hospital. Also, polypharmacy and inappropriate medication use occurred 
during transitions caused ADEs of HF patients. Therefore, the site started implementing 
pharmacy-led medication reconciliation which included the pharmacist, resident, and student 
from 2011. Admission and discharge medication review was conducted as well as counseling 
for the patient with HF. HF patients were categorized into scores from 0 to 8, with 0-2 
indicating a low risk for readmission, 3-5 indicating a moderate risk, and 6-8 indicating a 
high risk. The category model was previously developed by Kansagara et al. (2011). If a 
patient’s readmission risk was moderate or high, a score of 3 or greater, patients were 
qualified for a new prescription. The program resulted in reduction of a 30-day readmission 
from 2011 to 2013. The readmission rate of patient with moderate to high risk patient was 
lower 11.9 percent (5 of 42 patients) versus 15.3 percent (24 of 155 patients). Then, all HF 
patients’ 30-day readmission rate improved from 17 percent (82 of 471 admissions) to 15 
percent (76 of 498 admissions). For each avoided readmission, there was an associated 
decrease of $5,652 in variable costs (Guandi et al., 2015). 
 
Arnold, Buys & Fullas (2015) conducted a prospective study to examine whether 
pharmacist-led hospital follow-up for the patient versus physician alone would show a 
difference with respect to increased quality and improved care coordination when 
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pharmacists worked in conjunction with physicians. Previous year’s readmission data for 
high risk patients (older than 50 years old and taking more than 5 medications) who received 
only physician visits were collected for comparison with those who were jointly visited by 
pharmacists and physicians. A total of 98 patients received a pharmacist intervention in 
conjunction with hospital follow-up visits at physicians’ offices. Pharmacists formed a team 
and performed medication reconciliations and comprehensive chart reviews assessing 
accuracy of medication history, as well as monitoring of medication therapy and evidence-
based chronic disease state management. Then, those interventions were provided to the 
patients’ physicians. Patients seen by both pharmacists and physicians who were readmitted 
to a hospital within 30 days of discharge was 9.2%, whereas 19.4% was readmitted during the 
previous year of only physicians’ follow-up. The difference was statistically significant (p = 
0.023) and suggested that pharmacist intervention reduced overall readmission rate in high-
risk patients (Arnold, Buys &Fullas, 2015). Another study, which was a prospective, 
historical control study at Yale-New Haven Hospital, conducted a six-month period of 
pharmacy-facilitated medication reconciliation to a general medicine unit with the highest 30-
day readmission rate (Zemaitis, Morris, Cabie, Abdelghany, & Lee, 2016). Pharmacy 
technicians compiled the medication reconciliation information and counseling and discharge 
phone calls were done with the pharmacist at the patient’s primary team. Medication 
reconciliation information was reviewed by the pharmacist before discharge. Then the 
preceding 6 months with intervention period was compared and 465 patient received 
pharmacy intervention and the outcomes showed a 27 percent reduction in readmission 
during the intervention period. Meanwhile, educated pharmacy technicians showed similar 
benefits when compared with pharmacists. The pharmacists guided pharmacy technicians 
until they were able to perform medication reconciliation, counseling, and give phone calls to 
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patients. Then, pharmacist made sure everything was correct when pharmacy technicians had 
completed the reconciliation process (Zemaitis, Morris, Cabie, Abdelghany, & Lee, 2016). 
 
 
Pal, Babbott& Wilkinson (2013) conducted a prospective, nonrandomized cohort 
study which examined the impact of pharmacist-delivered medication reconciliation on 30 
day readmission rates; they were also interested in understanding the role of polypharmacy in 
the effectiveness of the intervention. Polypharmacy was categorized as a patient taking more 
than 10 drugs. Pharmacists provided medication counseling for each patient, and problem 
pharmacists used teach-back methods to confirm patient understanding specifically for 
problem medication. Problem medications were medications that have high possibilities of 
drug related problems if consumed wrong, such as insulin and warfarin. In addition to 
individual counseling, pharmacists verified prior patients’ medication and over the counter 
medication. A total of 729 patients were discharged, and those patients receiving pharmacy 
discharge review (n=537) were compared to those without pharmacy discharge review (n= 
192).The 30-day readmission rate was 16.8 percent among the pharmacy review group vs 
26.0 percent among the no-review group; this difference was statistically significant (p=.006). 
There was a progressive increase in 30-day readmission rates as the number of medications 
increased (Pal, Babbott& Wilkinson, 2013).   
 
Paquin et al. (2015) evaluated the effect of Pharmacological Intervention in Late Life 
(PILL) service that provided pharmacist telephone follow-up after discharge of elderly from 
the hospital. Telephone follow-up included medication reconciliation within 5 days after 
discharge. This study was a retrospective secondary data analysis from 2010 to 2012 that 
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included 501 high risk participants (older than 65 who was ordered for medication of acetyl 
cholinesterase inhibitor [donepezil, glantamin, rivastigmine] or N-methyl-D-aspartate 
antagonist [memantine] or inpatient who had risk of developing delirium, as indicated by 
cognitive impairment, sensory impairment, or dehydration). Of the participants, 98% were 
male. The average number of discharge medications was 14.8 ± 5.7 with 2.8 ± 2.2 medication 
changes and 1.4 ± 1.8 discrepancies between medication order and every additional 5 minutes 
of pharmacist-led medication reconciliation on telephone calls was associated with a 15% 
reduction in 60-day readmission which also had statistical significance. Li, et al. (2016) 
conducted a prospective pilot study that included adult patients who were discharged from 
the pilot unit from January 5 to January 30, 2015. 131 patients were screened and 94 patients 
were included because patients were expired during hospitalization or transferred to another 
unit or facilities. Pilot data were collected prospectively via electronic chart review and 
historical data for patients retrieved using the same inclusion and exclusion criteria. Primary 
outcome of 30-day readmission rate was 12.8% in the pilot group vs. 18.8% of participants in 
historical control, but there was no statistical significance (p= 0.26). Katelin et al. (2015) 
conducted a pilot study with a historical control. Patients were included if they had 
pneumonia and any of the following high-risk criteria: admission within 6 months, at least 5 
scheduled home medications, COPD, or HF. A retrospective chart review was conducted to 
compile the historical control group that received usual care. The intervention included 
medication reconciliation, therapeutic recommendation, and follow-up phone calls by the 
pharmacists. There was a trend toward a reduced 30-day readmission rate in the intervention 
group (n= 43) compared to usual care (n= 65) (27.9% vs. 40.0%; 95% CI, 0.3965-1.2278; p = 
0.2119).         
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Tedesco et al. (2016) conducted a pilot study to evaluate the effect transition of care 
follow-up and counseling performed by a pharmacist at physicians’ practices on patients’ 30 
day hospital readmissions. The study used two locations, one in Pittsburgh and one in 
Uniontown. The Pittsburgh site was selected for the intervention because of academic 
partnership with a school of pharmacy and the presence of the primary pharmacist researcher 
within the office. The Uniontown site was selected as the control site because of its similarity 
to the Pittsburgh site in terms of population size, number of physicians, and patient 
demographics, such as age, gender and insurance status. A pharmacy team, consisting of 2 
pharmacists and at least two rotation student pharmacists in the intervention group, contacted 
patients via telephone within 3 business days of their hospital discharge. Medication 
reconciliation and hospital’s instructions with regard to discharge counseling were given and 
the pharmacy team ensured that patients understood how to take their medications, identified 
any barriers to treatment, and answered questions. Then, all patients were advised to schedule 
for an appointment with their physicians within 7 days (and within 14 days when schedule 
did not allow). Once the schedule was set, the patient was then asked to report one and a half 
hour prior to their appointment for a face-to-face meeting with the pharmacist. Intervention 
group had total 34 patients that had 18 patients who contacted a pharmacist only via 
telephone, and 16 with both phone and face-to-face appointments. Then the control group had 
43 patients who didn’t interact with the pharmacy team. The readmission rates for the control 
and intervention groups were 26.7 percent and 14.7 percent, respectively. However, the 
difference was not statistically significant (p = .27). However, the statistically significant 
difference (p=.026) on readmission rates of patients who interacted with pharmacist face-to-
face in the intervention group was (0 percent) versus those in the control group with no 
pharmacist interaction (26.7 percent). Of the 18 patients who interacted with the pharmacist 
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via phone only, 5 were readmitted to the hospital within 30 days, while none of the 16 
patients who interacted with the pharmacist face-to-face were readmitted within the 30-day 
window. This result was marginally significant (p = .05).     
 
Farris et al. (2014) conducted an RCT of 945 participants to determine if a 
pharmacist case manager providing a faxed discharge medication care plan from a tertiary 
care institution to primary care could lower ADEs, re-hospitalization, and emergency 
department visits. A minimal intervention group and an enhanced intervention group were 
compared from 2007 to 2012. The minimal group received medication reconciliation, patient 
education, discharge medication list, and the enhanced group faxed medication care plans to 
their community physicians and conducted pharmacy telephone calls 3-5 days post-discharge. 
There were no statistically significant differences in 30-day readmission rate or ADEs. The 
pharmacy case manager did not affect the result as both groups were receiving a high quality 
of care. Other RCT conducted by Briggs et al. (2015) compared the intervention to current 
practice. Intervention was that a single pharmacist reviewed the medications of older for 
patients at the single site. Patients were included in the study if they lived at home and 
reported taking more than five medications, and were excluded if lived in a residential aged 
care. The odds of admission decreased with the intervention (odds ratio [OR]=0.68, 95% CI: 
0.53-0.87; p = 0.002). 
 
A RCT conducted by Bell et al. (2016) was designed to determine the effect of the 
Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) on 
unplanned health care utilization, including hospital readmission or emergency room (ER) 
visit, following discharge. The study was a randomized controlled trial with concealed 
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allocation, and blinded outcomes assessors at two academic medical centers: Vanderbilt 
University Hospital (VUH) and Brigham and Women’s Hospital (BWH) between May 2008 
and September 2009. Participants were randomly assigned to receive usual care or 
intervention in a 1-to1 ratio. The intervention included pharmacist-led medication 
reconciliation, inpatient counseling, low-literacy adherence aids and individualized telephone 
follow-up after discharge. Health literacy was defined as the degree to which individuals have 
the capacity to understand basic health information and services needed to make appropriate 
health decisions. Patients aged 18 and older who were hospitalized for acute coronary 
syndromes (ACS) and/or acute decompensated heart failure (ADHF) were recruited and the 
disease was determined by a physician. Test of Functional Health Literacy in Adults were 
administered to measure health literacy. Scores ranged from 0 to 36, with higher scores 
indicating higher health literacy. Primary outcome was time for first unplanned health care 
event and secondary outcomes were readmission or ER visit within 30 days. Usual care in 
each hospital included the nurses, pharmacists, and physicians involved in the patients’ care 
with medication reconciliation and counseling. Post-discharge follow-up calls were not 
routinely performed in usual care group. Then intervention group had specific component in 
each intervention such as pharmacists-reconciled preadmission medications, discharge 
medications with the patient, providing tailored counseling that assesses patient 
understanding of the medication regimen, and barriers to medication adherence. Then at 
discharge, the pharmacist provided additional counseling with teach-back technique and lastly, 
within four days of discharge, study coordinators contacted patients for any regimen 
confusion, symptoms, non-adherence or side-effects. If issues were raised, the coordinator 
contacted pharmacists to help the patients. A sample size of 862 patients calculated based on 
the primary outcome of the study design for adequate statistical power. However, seven 
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intervention patients and four usual-care patients died during hospitalization or withdrew 
consent. Thus, 851 patients were enrolled of which 423 were intervention (197 VUH and 226 
BWH) and 428 usual-care (200 VUH and 228 BWH). The primary outcome did not show a 
statistically significant difference, adjusted HR (risk of outcome over 30 days with 
intervention, using usual-care group as reference) =1.04 (95 percent CI 0.78 – 1.39). HR 
adjustment included age, sex, race, marital status, insurance type, study site, presence of PCP, 
cognitive status, diagnosis, length of stay, number of discharge medications, presence of prior 
hospitalizations and health literacy. Secondary outcomes also showed no statistical 
significance between intervention and control groups, adjusted HR for ER visits was 1.03 (95 
percent CI 0.76 – 1.39). Meanwhile, there was a significant interaction of treatment effect 
with patients’ health literacy level. The intervention reduced early, unplanned health care 
utilization among patients with inadequate health literacy (adjusted HR = 0.41, 95 percent CI 
0.17-1.00 p = 0.03), but not among patient with adequate health literacy (adjusted HR = 1.07, 
95 percent CI 0.77 – 1.48). ER visits among those intervention patients with inadequate 
health literacy was (adjusted HR= 0.29, 95 percent CI 0.11-0.78 p=0.01)          
 
A systematic review by Renaudin et al. (2016) identified studies from Medline and 
Cochrane Library databases. The inclusion criteria for studies were randomized controlled 
trial (RCT), pharmacist-led medication review versus usual care and emergency department 
(ED) visits at different time points. Primary outcomes were all-cause readmissions, all-cause 
ED visits, and secondary outcomes were drug-related readmissions and quality of life. Out of 
19 RCT studies, the readmission rates did not differ between pharmacist care and usual care 
group (RR = 0.97, 95 percent CI; 1.05, p=0.470).The secondary outcomes did not differ 
between the groups except for drug-related readmissions, which were lower in the pharmacy-
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led group (RR= 0.25, 95 percent CI 0.14; 0.45, p < 0.001), and all-cause ED visits (RR=0.70, 
95 percent CI 0.59; 0.85 p=0.001).   
 
Parajuli et al. (2017) conducted a systematic review that examined the role of the 
pharmacists for improving self-care in HF. Similar to other chronic diseases, HF requires 
patients to conduct self-care to minimize progression of disease. It has multiple comorbidities 
as well as unusually high hospital readmissions. The review searched different databases: 
Medline, PubMed, Scopus, EBSCO and Web of Science from 2013 through to October 2016. 
Applied keywords for searching were “heart failure” OR “left ventricular dysfunction” OR 
“cardiomyopathy” OR “left ventricular ejection fraction” OR “LV dysfunction” OR “systolic 
dysfunction” OR “diastolic dysfunction” OR “cardiac failure” OR “preserved ejection 
fraction” OR “HFpEF” OR “reduced ejection fraction” OR “HFrEF” AND pharmacist OR 
“pharmaceutical care” OR “pharmaceutical service” AND “self-care” OR “self-management” 
OR “self-monitoring” OR “self-efficacy”. Out of 82 articles defined, 49 articles were 
identified after excluding duplicates. After further review of title and abstract, 14 articles 
were remained to review. Although studies had significant heterogeneity such as having 
different models of care, patient populations and study designs, pharmacists involvement in 
HF patients have improved drug adherence, decreased 30-day readmission, increased patient 
satisfaction and increased patients’ in HF knowledge. However, some studies have shown 
mixed results for improvement in readmission rates possibly due to heterogeneity of the 
studies and different lengths of follow up. Meanwhile it was clear that pharmacist improved 
medication management improved patients’ self-care behaviors such as drug adherence. 
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Chapter 4 Strength & Limitations 
 
4.1 Strengths  
 
Several studies (Pal, Babbott & Wilkinson, 2013; Zemaitis, Morris, Cabie, 
Abdelghany, & Lee, 2016; Arnold, Buys & Fullas, 2015; Sebaaly et al., 2015) used a 
prospective study design which was a strength because, researchers began collecting data at 
baseline and thus could observe the data as time goes. These studies were able to measure 
incidence, prevalence, and multiple outcomes. 
 
Two studies (Parajuli et al. 2017; Renaudin et al. 2016) have done a systematic 
review. These reviews have reviewed current RCT studies, which are reliable as they are 
evidence-based. Guandi et al., (2015) and observational pre-post analysis by Anderegg, et al., 
(2014) had strength as the study could suggest that outcome was impacted by an intervention. 
The studies conducted by (Farris et al., 2014; Bell et al., 2016; Briggs et al., 2015) employed 
a RCT design, which increases the ability for researchers to evaluate the influence of the 
various interventions on outcomes of interest.  
 
4.2 Limitations 
 
Several studies were done at a single facility with unique population (Pal, A., Babbott, 
S., & Wilkinson, S. T. 2013; Anderegg et al., 2014; Guandi et al., 2015; Paquin et al. 2015) 
and thus the results of these studies may not be generalizable to other people or situation.    
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Inadequate sample size is another limitation in several studies (Tedesco, G. W., 
Mcconaha, J. L., Skomo, M. L., & Higginbotham, S. K. 2016). It limits the study’s power and 
makes conclusions difficult to draw. Systematic reviews (Parajuli et al., 2017 Renaudin et al. 
2016) had its limitation on target population and medications reviewed in the studies differed 
too much to have external validities. Since the RCT by Briggs et al. (2015) involved only one 
pharmacist who is an experienced pharmacist, similar results may not be seen in other studies. 
A large portion of RCT studies included a small number of subjects which raises concern on 
the likelihood that it may reduce a statistically significant result, a true effect. There would be 
a possibility that non-English publications on journals would have statistically significant 
findings as the searches were limited to English. Also, there were common limitations of the 
studies on confounding factors such as patients' ability to obtain needed medication after 
discharge, patient readiness for discharge, and readmissions caused by reasons unrelated. 
These factors may have affected readmission rate, even though they were unaccounted.     
 
Several pilot design studies (Tedesco, G. W., Mcconaha, J. L., Skomo, M. L., & 
Higginbotham, S. K. 2016; Sebaaly et al. 2015; Paquin et al. 2015; Guandi et al., 2015) 
reduced number of samples and duration of study, which possibly leading to type II     
error particularly on patients’ readmission rate. Failing to reject false null hypothesis would 
be the difference in readmission rate in this case as more patients were enrolled which 
lowered readmission rate. Also, checking severity scale on patients’ condition (Sebaaly et al., 
2015 Bell et al. 2016) may be biased as each pharmacist could rate a condition differently.  
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Chapter 5 Recommendations for Future Research 
 
Of the studies that have been reviewed, the results from studies which have evaluated 
the effectiveness of involving pharmacists in patient care to reduce 30-day hospital 
readmission are mixed. One of the important consequence of reducing hospital readmission is 
lowering cost for the healthcare system and benefit the public health overall. As Farris et al., 
(2014) suggests doing more is not a necessary step to lower hospital readmission rate, finding 
a cost-effective use of pharmacist-led medication reconciliation is essential. Since there is 
evidence that educated pharmacy technicians and interns demonstrate similar outcomes when 
compared to pharmacists, there should be more research about the role and efficiency of 
pharmacy technicians, pharmacy interns, and pharmacy residents. Then, most importantly, 
future research requires RCTs with  large sample sizes. The current literature does not have 
RCTs with adequate sample sizes such that results that can be generalized. If possible, these 
RCTs should address confounding factors such as patient adherence, quality of life of patients, 
then develop a severity scale of diseases for a precise assumption of potential savings. There 
are many barriers for implementing these RCTs as well as building successful programs or 
models. First, the study must be done in regards to every disease which is not feasible. 
Therefore, each hospital or any healthcare setting should set up the priorities on disease 
control. For example, hospitals can focus on conditions that CMS listed to avoid penalties. 
Second, the generalizable model requires a large population of demographics as every race 
holds different characteristics for their treatment. However, it is impossible due to the nature 
of hospital setting where a patient is admitted and discharged frequently. To address this issue, 
the study must be done nationally or even internationally with the organizations that can 
collaborate and hold accreditation by the Joint Commission for example. Also, future studies 
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should address the association between the socio-economic status of patient and readmission 
for more specific interventions of pharmacists. Lastly, other than 30-day hospital readmission 
rate, there should be more performance measuring keys for pharmacists as they involve in the 
variety of settings such as counseling patient, medication reconciliation discharge medication, 
phone calls and collaboration with other healthcare providers. 
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Chapter 6 Practice and Policy Implications 
 
The ACA has opened an unparalleled opportunity for pharmacists in the current 
healthcare system. Pharmacists are an integral part of health care team through medication 
reconciliation, ensuring patient education on medication by providing counseling, 
coordinating a team for patient-centered care has been a key factor for hospitals and ACA 
itself. However, several studies suggest that the impact of pharmacist-led medication review 
is not clear. Even with mixed results, pharmacist-led medication reconciliation had significant 
impact on improving drug-related readmissions, low health literacy patients, and cost 
containment of unnecessary spending in U.S. healthcare. If involving pharmacists 
everywhere are not panaceas to reduce all cause hospital readmission, the key would be 
involving pharmacists effectively. For example, pharmacists seeing patients face-to-face 
before patients’ physicians’ appointment decreased readmission rates. Also, Arnold, Buys & 
Fullas, (2015) found a huge improvement in the effectiveness of pharmacists when 
pharmacists worked with physicians. Future healthcare requires coordination of care to 
improve care transition and the study. A change and shift from pay-for-service to the pay-for-
performance model will require more and more coordination and communication between 
healthcare providers.  
 
During the transition, Anderegg et al., (2014) integrated educational opportunities 
into the process and pharmacy resident and student skill sets were developed and refined. 
Zemaitis, Morris, Cabie, Abdelghany, & Lee, (2016) expanded the role of pharmacy 
technicians in medication reconciliation to save time of clinical pharmacist by providing a 
training program on pharmacy technicians. As technicians are essential in pharmacy and the 
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study demonstrated the feasibility of incorporating pharmacy technicians in the medication 
reconciliation process, working as a team would save tremendous time and cost as the 
effectiveness on readmission did not differ significantly. Also, they found technicians holding 
retail pharmacy experience were doing better at patient interview as they have done customer 
service before (Pal, Babbott& Wilkinson, 2013). 
 
In regards to Hospital, target goal of hospital readmission would vary according to 
their status. Hospitals that have not used pharmacists to lower readmission rate should begin 
with medication reconciliation program led by pharmacists. However, if pharmacist-led 
medication reconciliation intervention does not show adequate results, keep pushing it would 
not help. Since the budget for any hospital is not infinite, finding hospital specific solution 
would be a key to lower hospital readmission. As seen in previous reviews, those hospitals 
with many high risk patients (patients taking more than 5 drugs and/or taking problematic 
drugs depending on diseases) or limited health literacy may focus on treating those patients in 
order to avoid penalties from CMS.  
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Conclusion 
 
The ACA established the Hospital Readmission Reduction Program that allows CMS 
to reduce payments to hospitals that have excess 30-day readmission. Even with mixed 
results, pharmacist-led medication reconciliation showed cost savings and the fact 
pharmacists are positioned to provide their expertise on medications to help patients never 
changes. In response to possible penalties, a hospital may target patients at high risk to reduce 
readmission rate. More research, especially a RCT with large sample is needed to evaluate 
cost-effectiveness of pharmacy team and to investigate other risk factors that show clear 
relationship with hospital readmission.  
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